Key result
Mitral valve replacement with Model 6310-6320 prostheses yielded a 10-year projected rate of survival free of embolus similar to that observed for Model 6120 prostheses (50% vs 46%).
Why the study?
Does the choice of prosthesis model affect long-term survival and freedom from embolus in patients undergoing isolated mitral valve replacement?
Cohort (n=290)
Does the choice of prosthesis model affect long-term survival and freedom from embolus in patients undergoing isolated mitral valve replacement?
Absolute Event Rate: 50% vs 46%
Long-term survival after isolated mitral valve replacement is influenced by preoperative functional class, pulmonary vascular resistance, and pump time, with comparable long-term performance between different prosthesis models.
Similar performance should not alter prosthesis choice; leaves open randomized mitral valve comparisons.
The timing of operation and the selection of prosthesis depend upon the evaluation of long-term results at 5 years and beyond. From 1965 to 1975, 290 patients had isolated mitral valve replacement with currently used prostheses, resulting in a 6.6% operative mortality and 64% relative survival at 10 years. In considering mortality, the results obtained with both series of valves were combined and a search made for significant differences in preoperative variables between the operative deaths and operative survivors. The significant variables for operative mortality were valve model, preoperative functional class, pump time, and the presence or absence of right ventricular hypertrophy on electrocardiography. There were significant differences in long-term survival only with regard to preoperative functional class, pulmonary vascular resistance, and pump time. Exponential curves were fitted to the event-free rates, and long-term results were then extrapolated. The 10-year projection of the percentage of patients alive and free of embolus (disregarding transient ischemic attacks) for the Model 6310-6320 (50%) was similar to that actually observed for the Model 6120 (46%). Although further experience may show one prosthesis more effective than the other, statistical extrapolations suggest continued comparable performance.
No takes yet. Share an insight, caveat, or question.
Criley et al. (1977) conducted a cohort in Isolated mitral valve replacement (n=290). Model 6310-6320 prosthesis vs. Model 6120 prosthesis was evaluated on Alive and free of embolus at 10 years. Mitral valve replacement with Model 6310-6320 prostheses yielded a 10-year projected rate of survival free of embolus similar to that observed for Model 6120 prostheses (50% vs 46%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: